Navigation Links
LA BioMed to honor 3 of its legendary
Date:4/10/2008

nvolved in more than 20 grants and research awards to study new techniques for the treatment of intracranial aneurysms, arteriovenous malformations, cerebrovascular thrombolysis and angioplasty.

In 1997, he was honored by the Joint Section of Cerebrovascular Surgery with a Lifetime Achievement Award. In 1999, he received the Luessenhop Award as well as the exclusive Gold Medal from the American Society of Neuroradiology.

He is retired and lives with his wife, Donna, in Huntington Beach.

Dr. Turner

Dr. Turner first became interested in tropical diseases when he was in junior high school. As a medical student at UCLA, he worked with the faculty of the Division of Parasitology in the Department of Infectious Diseases. His summer parasitology research project in Guatemala was interrupted when he acquired paralytic poliomyelitis, an acute onset of paralysis.

After weeks in a Guatemalan hospital, he was transferred to the student health section of the UCLA Medical Center for rehabilitation. A year later, he joined the Class of 1958 for his senior year of medical school.

After an internal medicine internship at the UCLA Medical Center, Turner rejoined the Division of Parasitology as a faculty member and began his academic teaching career. He studied tropical medicine in Puerto Rico, Haiti, Mexico, South Africa, Kenya and Egypt. He also obtained a diploma in tropical medicine and hygiene from the London School of Hygiene and Tropical Medicine.

Dr. Turner returned to clinical internal medicine by joining the residency program at Harbor-UCLA Medical Center in 1964. He taught parasitology at UCLA until retirement, earning four "Golden Apple Teaching Awards" and an "Exceptional Quality Teaching Award" from the medical students. He also taught parasitology at the University of California, Irvine College of Medicine.

Dr. Turner served in several administrative roles at Harbor-UCLA Medical Center. Hes
'/>"/>

Contact: Laura Mecoy
Lmecoy@issuesmanagement.com
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. Response Biomedical Corporation Reports 2007 Financial Results
2. Response Biomedical Corporation Moves to New Facility
3. Response Biomedical Corp. - Year End 2007 Earnings Webcast and Conference Call - March 31, 2008
4. LA BioMed researcher says unexpected increase in cancer risk found
5. LA BioMed study finds hormone therapy increases frequency of abnormal mammograms, breast biopsies
6. BioMed Realty Trust Joint Venture Enters Into New $245 Million Construction Loan and Extends Term of Existing Loan Facility
7. Dr. Inder Verma named recipient of 2008 Vilcek Prize in biomedical science
8. 7th Annual Wiley Prize in Biomedical Sciences Awarded to Dr. Richard P. Lifton
9. Lung Cancer Alliance Urges Inclusion of $5 Billion for Biomedical Research in Economic Stimulus Package
10. BioMed Central bolsters radiology image collection
11. New nanotube findings by Stanford researchers give boost to potential biomedical applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... protein beta-amyloid is strongly associated with Alzheimer,s disease; however, ... peptide is the causal agent of the onset and ... confirmation is that beta-amyloid is not harmful when found ... when it self-assembles to form the so-called amyloid fibrils ... beta-amyloid alone, but with multiple ones because each aggregate ...
(Date:10/1/2014)... new research study published today in the Journal ... patients older than 50 years with moderate or severe ... , Researchers from the University of Melbourne randomly assigned ... pain to no acupuncture or sham or pretend laser ... with participants and acupuncturists blinded to laser and sham ...
(Date:10/1/2014)... Physical Sciences Research Council (EPSRC) will focus on ... systems which run, for example, manufacturing plants, power ... , The research will help understand and ... systems behind our critical national infrastructure. , ... (RITICS), based at Imperial College London, is co-ordinating ...
(Date:10/1/2014)... BOSTON (October 1, 2014) Despite a policy ... with developmental disabilities, this vulnerable population continues to ... of The Journal of the American Dental ... Medicine and Tufts University School of Dental Medicine ... factors influencing at-home oral care provided by caregivers ...
(Date:10/1/2014)... 2014 Familylifeinsurancequotes.org has released a ... for senior citizens. , Senior citizens can qualify ... sell coverage to seniors who are over 50 years ... without taking a medical examination. , Term life insurance ... senior clients can qualify. Having life insurance during retirement ...
Breaking Medicine News(10 mins):Health News:Laying siege to beta-amyloid, the key protein in Alzheimer's disease 2Health News:Study finds acupuncture does not improve chronic knee pain 2Health News:£2.5 million to recognize and reduce cyber-attack threats to critical infrastructure 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Affordable Term Life Insurance - Senior Citizens Can Qualify for Coverage! 2
... an Army leader and a military surgeon are among the ... the Henry M. Jackson Foundation for the Advancement of Military ... which will take place at the National Museum of Women ... by service members, veterans and civilians who are working together ...
... News) -- Prenatal diagnosis, early surgery and well-coordinated care by ... cleft lip and/or cleft palate, experts say. Cleft lip ... pregnancy when the roof of the mouth fails to fuse ... United States each year and is the second most common ...
... Tierney, M.D., president and CEO of the Regenstrief Institute ... Indiana University School of Medicine, received a 2011 Distinguished ... and Education Meeting on April 28 in Washington, DC. ... Achievement and Contribution to Clinical and Translational Science. He ...
... A gene known to be important in cardiac development ... result in obstruction of the left ventricular outflow tract. ... Nationwide Children,s Hospital and appearing in the journal ... outflow tract (LVOT) malformations, including aortic valve stenosis, coarctation ...
... Australia and Europe. Large resources are set aside for research ... the research field is still new but researchers from ... years ago the Norwegian health care system had a low ... sectors", says Professor Karina Aase at the University of Stavanger. ...
... in powerful positions are just as likely as men to cheat ... that men are more likely than women to cheat on their ... gender, according to the study published April 28 in the journal ... research in the past that indicates that gender is the strongest ...
Cached Medicine News:Health News:Dinner to honor icons of military medicine 2Health News:Early Surgery Boosts Outcomes for Babies With Cleft Palate 2Health News:Tierney named 2011 Clinical and Translational Research Distinguished Investigator 2Health News:Study identifies second gene associated with specific congenital heart defects 2Health News:Sustaining vulnerable lives 2Health News:Sustaining vulnerable lives 3Health News:Powerful Women as Likely to Cheat as Men, Study Finds 2
(Date:10/1/2014)... 2014  Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), ... technology used to develop and produce enzymes and ... and industrial enzymes industries, today announced the receipt ... for commercial scale production of Abengoa,s proprietary cellulase ... under Abengoa,s license agreement with Dyadic. ...
(Date:10/1/2014)... 2014 NeuroCall, Inc., ("NeuroCall") announced today that ... and Teleneurology services. Dr. Ricardo Garcia-Rivera , Founder ... extremely proud that our quality of service has been ... provide lifesaving support and continuity of care to patients ... the United States ." ...
(Date:10/1/2014)... LOUIS , Oct. 1, 2014  Express Scripts ... two nationally available 2015 Express Scripts Medicare ® ... pharmacy network featuring Walgreens (NYSE: WAG ) ... more value, choice and clinical support  for their Medicare ... Express Scripts Medicare Value or Choice ...
Breaking Medicine Technology:Dyadic International Reports Licensing Payment For Commercial-Scale Production Of C1-Based Cellulase Enzymes 2Dyadic International Reports Licensing Payment For Commercial-Scale Production Of C1-Based Cellulase Enzymes 3NeuroCall Awarded Joint Commission Accreditation 2Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network 2Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network 3Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network 4
... -- LEUVEN, Belgium, September 6, 2010 ... ... ... are keyed by longUrl, so we need to grab the first one. for (var r in data.results) ...
... O R R E C T I O N - Mindray Medical... -- SHENZHEN, China, Aug. 25 /PRNewswire-Asia-FirstCall/ ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we need to ...
Cached Medicine Technology:ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 2ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 3ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 4ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 5ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 6ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 7ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 8ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 9ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 10/C O R R E C T I O N - Mindray Medical International Limited / 2/C O R R E C T I O N - Mindray Medical International Limited / 3/C O R R E C T I O N - Mindray Medical International Limited / 4/C O R R E C T I O N - Mindray Medical International Limited / 5/C O R R E C T I O N - Mindray Medical International Limited / 6/C O R R E C T I O N - Mindray Medical International Limited / 7
Double ended 1.75 mm by 30 mm sterling silver blade. Flat serrated handle with polished finish....
4 mm wide by 17.5 mm flat platinum spatula on 34 mm shaft. Flat serrated handle with polished finish. Most popular size or model....
... Duckbilled spatula designed to enter ... broad enough to efficiently manipulate the ... Spatula is useful for rotating and ... rounded tip with notch and curved ...
Double ended lasik spatula with flattened tip for lifting and smoothing the corneal flap. The sharp tip is useful to outline a previous flap in preparation for retreatment....
Medicine Products: